Bejon P

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.Olotu, A. Lusingu, J. Leach, A. Lievens, M. Vekemans, J. Msham, S. Lang, T. Gould, J. Dubois, M. C. Jongert, E. Vansadia, P. Carter, T. Njuguna, P. Awuondo, K. O. Malabeja, A. Abdul, O. Gesase, S. Mturi, N. Drakeley, C. J. Savarese, B. Villafana, T. Lapierre, D. Ballou, W. R. Cohen, J. Lemnge, M. M. Peshu, N. Marsh, K. Riley, E. M. von Seidlein, L. Bejon, P.
Lancet Infect Dis, (2011). 11:102-9

Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya.Olotu, A. Fegan, G. Williams, T. N. Sasi, P. Ogada, E. Bauni, E. Wambua, J. Marsh, K. Borrmann, S. Bejon, P.
PLoS One, (2010). 5:e15569

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.Lusingu, J. Olotu, A. Leach, A. Lievens, M. Vekemans, J. Olivier, A. Benns, S. Olomi, R. Msham, S. Lang, T. Gould, J. Hallez, K. Guerra, Y. Njuguna, P. Awuondo, K. O. Malabeja, A. Abdul, O. Gesase, S. Dekker, D. Malle, L. Ismael, S. Mturi, N. Drakeley, C. J. Savarese, B. Villafana, T. Ballou, W. R. Cohen, J. Riley, E. M. Lemnge, M. M. Marsh, K. Bejon, P. von Seidlein, L.
PLoS One, (2010). 5:e14090

Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya.Bejon, P. Williams, T. N. Liljander, A. Noor, A. M. Wambua, J. Ogada, E. Olotu, A. Osier, F. H. Hay, S. I. Farnert, A. Marsh, K.
PLoS Med, (2010). 7:e1000304

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.Olotu, A. I. Fegan, G. Bejon, P.
J Infect Dis, (2010). 201:970-1

Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.Mwacharo, J. Dunachie, S. J. Kai, O. Hill, A. V. Bejon, P. Fletcher, H. A.
PLoS One, (2009). 4:e8434

Interactions between age and ITN use determine the risk of febrile malaria in children.Bejon, P. Ogada, E. Peshu, N. Marsh, K.
PLoS One, (2009). 4:e8321

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.Kinyanjui, S. M. Bejon, P. Osier, F. H. Bull, P. C. Marsh, K.
Malar J, (2009). 8:242

Multiple functions of human T cells generated by experimental malaria challenge.Todryk, S. M. Walther, M. Bejon, P. Hutchings, C. Thompson, F. M. Urban, B. C. Porter, D. W. Hill, A. V.
Eur J Immunol, (2009). 39:3042-51

HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria.Berkley, J. A. Bejon, P. Mwangi, T. Gwer, S. Maitland, K. Williams, T. N. Mohammed, S. Osier, F. Kinyanjui, S. Fegan, G. Lowe, B. S. English, M. Peshu, N. Marsh, K. Newton, C. R.
Clin Infect Dis, (2009). 49:336-43

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".Bejon, P. Abdulla, S. Lusingu, J. Olotu, A. Leach, A. Lievens, M. Tanner, M. von Seidlein, L.
Vaccine, (2009). 27:4745-6

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.Dudareva, M. Andrews, L. Gilbert, S. C. Bejon, P. Marsh, K. Mwacharo, J. Kai, O. Nicosia, A. Hill, A. V.
Vaccine, (2009). 27:3501-4

Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.Bejon, P. Warimwe, G. Mackintosh, C. L. Mackinnon, M. J. Kinyanjui, S. M. Musyoki, J. N. Bull, P. C. Marsh, K.
Infect Immun, (2009). 77:1917-23

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.Bejon, P. Lusingu, J. Olotu, A. Leach, A. Lievens, M. Vekemans, J. Mshamu, S. Lang, T. Gould, J. Dubois, M. C. Demoitie, M. A. Stallaert, J. F. Vansadia, P. Carter, T. Njuguna, P. Awuondo, K. O. Malabeja, A. Abdul, O. Gesase, S. Mturi, N. Drakeley, C. J. Savarese, B. Villafana, T. Ballou, W. R. Cohen, J. Riley, E. M. Lemnge, M. M. Marsh, K. von Seidlein, L.
N Engl J Med, (2008). 359:2521-32

Fraction of all hospital admissions and deaths attributable to malnutrition among children in rural Kenya.Bejon, P. Mohammed, S. Mwangi, I. Atkinson, S. H. Osier, F. Peshu, N. Newton, C. R. Maitland, K. Berkley, J. A.
Am J Clin Nutr, (2008). 88:1626-31

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.O'Meara, W. P. Bejon, P. Mwangi, T. W. Okiro, E. A. Peshu, N. Snow, R. W. Newton, C. R. Marsh, K.
Lancet, (2008). 372:1555-62

Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value.Sanderson, F. Andrews, L. Douglas, A. D. Hunt-Cooke, A. Bejon, P. Hill, A. V.
Am J Trop Med Hyg, (2008). 78:878-83

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.Todryk, S. M. Bejon, P. Mwangi, T. Plebanski, M. Urban, B. Marsh, K. Hill, A. V. Flanagan, K. L.
PLoS One, (2008). 3:e2027

Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast.Gikonyo, C. Bejon, P. Marsh, V. Molyneux, S.
Soc Sci Med, (2008). 67:708-20

Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.Agak, G. W. Bejon, P. Fegan, G. Gicheru, N. Villard, V. Kajava, A. V. Marsh, K. Corradin, G.
Vaccine, (2008). 26:1963-71